Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 120 Results Clear All
Rewatch The Audacity of Hope, a powerful webinar hosted in honor of World AIDS Day 2024.
HIV/AIDS Ott Lab
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Virology Ott Lab
The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.
Gladstone Experts Virology Ott Lab
Melanie Ott, director of the Gladstone Institute of Virology, reflects on the breakthroughs driven by the COVID-19 pandemic and explains why virologists’ work is never done
Gladstone Experts COVID-19 Virology Ott Lab
Fortune—Researchers are investigating the possibility that people who suffer from Long COVID might be at elevated risk of developing cancer. Melanie Ott, director of the Gladstone Institute of Virology, explains that viruses related to SARS-CoV-2 have been shown to inactivate oncosuppressor proteins, which may predispose patients to cancer.
Gladstone Experts Cancer COVID-19 Virology Ott Lab
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab
Mir Khalid, a scientist in the Ott Lab, explains his work on SARS-CoV-2, his long love of science, and how he spends his free time
Graduate Students and Postdocs Profile COVID-19 Ott Lab
New research sheds light on the biological effect of the many possible three-dimensional structures of a critical loop of RNA in HIV
Research (Publication) HIV/AIDS Virology Ott Lab
The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.
Gladstone Experts COVID-19 Virology Ott Lab
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
Watch this panel discussion that addresses the impact and hurdles associated with developing a cure for HIV
HIV/AIDS Ott Lab
Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.
Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs
The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies
News Release Research (Publication) COVID-19 Virology Doudna Lab Ott Lab
Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19
News Release Research (Publication) COVID-19 Virology Ott Lab
